Picture Berlin Partner Top News from HealthCapital Berlin-Brandenburg 650x100px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2922 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Exscientia plc. (12/5/23). "Press Release: Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza". Oxford. 2023-12-05
IBM Corporation. (12/5/23). "Press Release: AI Alliance Launches as an International Community of Leading Technology Developers, Researchers, and Adopters Collaborating Together to Advance Open, Safe, Responsible AI". 2023-12-05
Refeyn Ltd.. (11/30/23). "Press Release: Refeyn Launches KaritroMP for Rapid and Reproducible Characterization of Large Viral Vectors". Oxford. 2023-11-30
Freeline Therapeutics Holdings plc. (11/22/23). "Press Release: Syncona to Acquire Freeline Therapeutics". London. 2023-11-22
Quotient Therapeutics. (11/21/23). "Press Release: Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics". Cambridge, MA. 2023-11-21
Merck & Co., Inc.. (11/21/23). "Press Release: Merck to Acquire Caraway Therapeutics, Inc.". Rahway, NJ & Cambridge, MA. 2023-11-21
Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024". 2023-11-21
Exscientia plc. (11/21/23). "Press Release: Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference". Oxford. 2023-11-21
eXmoor Pharma Concepts Ltd.. (11/16/23). "Press Release: eXmoor Appoints Matthew Paterson as First Chief Commercial Officer". Bristol. 2023-11-16
T-Therapeutics Ltd.. (11/15/23). "Press Release: T-Therapeutics Raises £48 Million Series A for Development of Next Generation TCR Therapeutics to Transform Cancer Treatment". Cambridge. 2023-11-15
Glox Therapeutics Ltd.. (11/14/23). "Press Release: Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria". Glasgow. 2023-11-14
Autifony Therapeutics Ltd.. (11/14/23). "Press Release: Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders". Stevenage. 2023-11-14
ViaNautis Bio Ltd.. (11/13/23). "Press Release: ViaNautis Bio Announces $25 Million Series A Financing to Drive the Next Generation of Genetic Nanomedicines". Cambridge. 2023-11-13
Cromatic Inc.. (11/9/23). "Press Release: Cromatic Closes $5.3 Million in Oversubscribed Seed Round to Modernize Life Science R&D Outsourcing". Palo Alto, CA. 2023-11-09
Valneva S.E.. (11/7/23). "Press Release: Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference". Saint Herblain. 2023-11-07
Memo Therapeutics AG. (11/02/23). "Press Release: Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients". Schlieren. 2023-11-02
Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.. 2023-10-31
Bicycle Therapeutics plc. (10/30/23). "Press Release: Bicycle Therapeutics to Participate in Upcoming Investor Conferences". Cambridge. 2023-10-30
MeiraGTx Holdings plc. (10/30/23). "Press Release: MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities". London & New York, NY. 2023-10-30
OrbiMed Advisors LLC. (10/24/23). "Press Release: OrbiMed Raises $4.3 Billion Across Private Investment Funds". New York, NY. 2023-10-24
Nanoform Finland Oyj. (10/23/23). "Press Release: Nanoform Grant Global Starmap AI License to AstraZeneca". Helsinki. 2023-10-23
GSK plc. (10/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20089". London. 2023-10-20
bioMérieux S.A.. (10/19/23). "Press Release: bioMérieux Makes Strategic Investment in Oxford Nanopore". Oxford & Marcy-l’Etoile. 2023-10-19
Cresset Biomolecular Discovery Ltd.. (10/18/23). "Press Release: Cresset Targets International Growth with Innovate UK Scaleup Programme". Cambridge. 2023-10-18
Exscientia plc. (10/17/23). "Press Release: Parker Moss to Join Exscientia as EVP, Corporate Development". Oxford. 2023-10-17
Refeyn Ltd.. (10/17/23). "Press Release: Refeyn Expands the Analytical Possibilities for High Concentration Samples by MassFluidix HC". Oxford. 2023-10-17
Antiverse Ltd.. (10/16/23). "Press Release: Antiverse and GlobalBio, Inc. Extend Collaboration to Advance Antibody Cancer Therapeutics". Cardiff & Cambridge, MA. 2023-10-16
Sosei Group Corporation (d/b/a Sosei Heptares). (10/10/23). "Press Release: Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration". Tokyo & Cambridge. 2023-10-10
AstronauTx Ltd.. (10/9/23). "Press Release: AstronauTx Closes £48 Million ($61 Million) Series A Financing to Create New Treatments for Alzheimer’s Disease". London. 2023-10-09
LimmaTech Biologics AG. (10/9/23). "Press Release: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections". Schlieren. 2023-10-09
Medicines Discovery Catapult (MDC). (10/5/23). "Press Release: UK Launches Its First National Total-body PET Platform for Drug Discovery". 2023-10-05
Markes International Ltd.. (10/5/23). "Press Release: Schauenburg Analytics Ltd Announces Appointment of New CEO". 2023-10-05
EBD Group. (10/4/23). "Press Release: BIO-Europe Set to Break Records in Munich, Germany". Munich. 2023-10-04
Exscientia plc. (10/3/23). "Press Release: Exscientia Details Pipeline Prioritisation Strategy". Oxford. 2023-10-03
Refeyn Ltd.. (10/2/23). "Press Release: Refeyn Announces Appointment of New CEO". Oxford. 2023-10-02
Mogrify Ltd.. (10/2/23). "Press Release: Mogrify Extends Series A Financing to $46 Million USD". Cambridge. 2023-10-02
Broken String Biosciences Ltd.. (10/2/23). "Press Release: Broken String Biosciences Strengthens Senior Leadership Team to Accelerate Product Development and Commercialization". Cambridge. 2023-10-02
Laverock Therapeutics Ltd.. (9/28/23). "Press Release: Laverock Therapeutics Raises £13.5M to Develop Unique Gene Silencing Platform for Programmable Advanced Therapies". 2023-09-28
Sartorius AG. (9/28/23). "Press Release: Sartorius Forms Partnership with Sparta Biodiscovery on Novel Nanoparticle Analysis Platform". Göttingen. 2023-09-28
BioProtect Ltd.. (9/27/23). "Press Release: BioProtect Secures $28M to Commercialize Its Biodegradable Balloon for Rectal Protection During Prostate Cancer Radiation Therapy". Tzur Igal. 2023-09-27
Cytel Inc.. (9/26/23). "Press Release: Cytel Continues Expansion of Market Access and Medical Communication Capabilities with the Acquisition of Co.faktor". Waltham, MA. 2023-09-26
Biosynth AG. (9/25/23). "Press Release: Biosynth Extends its Offering to Multi-Kilogram GMP Peptide Synthesis through the Acquisition of Pepceuticals". Staad. 2023-09-25
Argobio S.A.S.. (9/25/23). "Press Release: Northern Gritstone and Argobio Studio Back Sheffield University Spin-out Crucible Therapeutics". Paris, Manchester & Sheffield. 2023-09-25
Exscientia plc. (9/20/23). "Press Release: Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany". Oxford. 2023-09-20
Oxford Biomedica plc. (9/20/23). "Press Release: Oxford Biomedica and Institut Mérieux Enter into Exclusive Negotiations with Respect to the Proposed Acquisition by Oxford Biomedica of ABL Europe". Oxford. 2023-09-20
BenevolentAI. (9/20/23). "Press Release: BenevolentAI Signs Strategic Collaboration with Merck". London. 2023-09-20
AstraZeneca plc. (9/20/23). "Press Release: Alexion Completes Purchase and Licence Agreement for Early-stage Rare Disease Gene Therapy Portfolio from Pfizer". 2023-09-20
Bionow (The Centre of Excellence for Life Sciences Ltd. trading as Bionow). (9/20/23). "Press Release: 2023 BioCap Conference Pitching Competition Finalists Announced". 2023-09-20
Merck KGaA. (9/20/23). "Press Release: Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery [Not intended for US-, Canada- or UK-based media]". Darmstadt. 2023-09-20
Rentschler Biopharma SE. (9/19/23). "Press Release: Rentschler Biopharma Appoints Benedikt von Braunmuehl as Chief Executive Officer". Laupheim, Stevenage & Milford, MA. 2023-09-19
Galapagos N.V.. (9/19/23). "Press Release: Galapagos Appoints Simon Sturge to Its Board of Directors". Mechelen. 2023-09-19
Broken String Biosciences Ltd.. (9/18/23). "Press Release: Broken String Biosciences Closes $15M Series A Funding Round". Cambridge. 2023-09-18
BenevolentAI. (9/18/23). "Press Release: BenevolentAI Welcomes Christina Busmalis as Its New Chief Revenue Officer". London. 2023-09-18
ICR Inc.. (9/12/23). "Press Release: ICR Acquires Consilium Strategic Communications, Creating Global Leader in Healthcare Communications and Investor Relations". New York, NY. 2023-09-12
Kuano Ltd.. (9/12/23). "Press Release: Kuano Raises £1.8M in Seed Funding Round to Accelerate Quantum Drug Discovery". Cambridge. 2023-09-12
Bastion Therapeutics Ltd.. (9/12/23). "Press Release: Bastion Therapeutics Secures Launch Financing to Develop Advanced Treg Therapeutics". London. 2023-09-12
BenevolentAI. (9/11/23). "Press Release: Appointment of Catherine Isted, ACMA, as Chief Financial Officer". London. 2023-09-11
Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA. 2023-09-11
Orbit Discovery Ltd.. (9/11/23). "Press Release: Orano Med and Orbit Discovery Enter Collaboration to Discover Novel Targeted Radioligand Therapies for Cancer". Texas & Oxford. 2023-09-11
Novartis AG. (9/11/23). "Press Release: Sandoz Announces Exclusive Deal to Commercialize Biosimilar Ustekinumab". Basel. 2023-09-11
Verge Analytics, Inc. (d/b/a Verge Genomics). (9/8/23). "Press Release: Verge Genomics Announces Artificial Intelligence-enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases". South San Francisco, CA. 2023-09-08
Corteria Pharmaceuticals S.A.S.. (9/7/23). "Press Release: Corteria Pharmaceuticals Announces a €65M ($71M) Financing to Advance Transformational Medicines in Cardiovascular Diseases". Paris. 2023-09-07
inContAlert GmbH. (9/6/23). "Press Release: Disruption in the Field of Incontinence. MedTech Startup inContAlert Raises EUR 1.5 Million". 2023-09-06
Optibrium Ltd.. (8/31/23). "Press Release: Optibrium Acquires BioPharmics LLC, Expanding Its 3D Drug Design and Visualisation Offering". Cambridge. 2023-08-31
Theragenix Ltd.. (8/31/23). "Press Release: Theragenix and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration". London & Nottingham. 2023-08-31
Exscientia plc. (8/31/23). "Press Release: Exscientia to Present at Upcoming Investor Conferences in September". Oxford. 2023-08-31
Intellegens Ltd.. (8/30/23). "Press Release: Intellegens and CPI Awarded £1.6m Innovate UK Grant to Advance Manufacture of Oligonucleotide Therapeutics with Machine Learning". Cambridge. 2023-08-30
CEPI. (8/29/23). "Press Release: CEPI and University of Oxford to Accelerate Vaccine Development against Disease X". Oslo & Oxford. 2023-08-29
Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC. 2023-08-28
Synthego Corporation. (8/24/23). "Press Release: Synthego and Expand Strategic Partnership to Build a Platform for the Development of Safer and More Efficient Genetic Engineering of Human Cells for Cell Therapies". Redwood City, CA & Cambridge. 2023-08-24
Rentschler Biopharma SE. (8/23/23). "Press Release: Collaboration to Improve Process Analytical Technologies and AAV Manufacturing for Gene Therapies". Stevenage, London & Laupheim. 2023-08-23
Mysthera Therapeutics AG. (8/21/23). "Press Release: Mysthera Therapeutics Launches to Develop First-in-Class Autoimmune Disease Therapies". Basel. 2023-08-21
Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)". 2023-08-21
Lindus Health Ltd.. (8/16/23). "Press Release: Announcing Our $18m Series A Led by Investors Creandum and with Participation from Peter Thiel". London. 2023-08-16
Refeyn Ltd.. (8/15/23). "Press Release: Refeyn Expands into AAV-based Gene Therapy Manufacturing with GMP Software". Oxford. 2023-08-15
Temedica GmbH. (8/2/23). "Press Release: Temedica and AbbVie Germany Are Launching Digital Companion for Patients with Chronic Inflammatory Bowel Diseases". 2023-08-02
Sygnature Discovery Ltd.. (7/31/23). "Press Release: Sygnature Discovery Accelerates Global Growth with Major North American Acquisition". 2023-07-31
NK:IO Ltd.. (7/25/23). "Press Release: NK:IO Raises £1.2M, Bringing Total Seed Funding to £5.1M, to Advance Pioneering NK Cell Therapy". London. 2023-07-25
Crescendo Biologics Ltd.. (7/24/23). "Press Release: Crescendo Biologics Secures $32m and Announces Expansion of CB307 Phase 1b Trial in PSMA+ Solid Tumours". Cambridge. 2023-07-24
Molecure S.A.. (7/21/23). "Press Release: Molecure Completes Successful Secondary Public Offering (SPO) of approximately PLN 50 Million (USD 12 Million)". Warsaw. 2023-07-21
Idorsia Ltd.. (7/20/23). "Press Release: Idorsia Sells Its Asia Pacific (ex-China) Operations – Including Select License Rights to Products – to Sosei Heptares for a Total Consideration of CHF 400 Million". Allschwil. 2023-07-20
LimmaTech Biologics AG. (7/20/23). "Press Release: GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine". Schlieren. 2023-07-20
BioGeneration Ventures B.V.. (7/19/23). "Press Release: Dr. Markus Kalousek and Dr. Andrew Lightfoot Join BGV as Venture Partners". Amsterdam. 2023-07-19
Accession Therapeutics Ltd.. (7/19/23). "Press Release: Chief Business Officer Appointed at Accession Therapeutics as Company Prepares for Clinical Trials". Oxford. 2023-07-19
Pieris Pharmaceuticals, Inc.. (7/18/23). "Press Release: Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring". Boston, MA. 2023-07-18
Bicycle Therapeutics plc. (7/18/23). "Press Release: Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Cambridg 2023-07-18
Illumina, Inc.. (7/18/23). "Press Release: The Alliance for Genomic Discovery Announces Founding Biopharma Members – AbbVie, Amgen, AstraZeneca, Bayer, and Merck". San Diego, CA. 2023-07-18
Flagship Pioneering. (7/18/23). "Press Release: Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs". Cambridge, MA & New York, NY. 2023-07-18
Saniona AB. (7/17/23). "Press Release: Saniona Enters into Collaboration Agreement with AstronauTx in Alzheimer’s Disease". 2023-07-17
Bicycle Therapeutics plc. (7/12/23). "Press Release: Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares". Cambridge & Boston, MA. 2023-07-12
Tenpoint Therapeutics Ltd.. (7/12/23). "Press Release: Tenpoint Therapeutics Launches with $70 Million Series A Financing to Reverse Vision Loss Through Engineered Cell-based Therapeutics and In Vivo Reprogramming". London. 2023-07-12
SparingVision S.A.S.. (7/12/23). "Press Release: SparingVision Sells Ex Vivo GIRK Technology to Tenpoint Therapeutics". Paris. 2023-07-12
Bicycle Therapeutics plc. (7/12/23). "Press Release: Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares". Cambridge & Boston, MA. 2023-07-12
Ramarketing & PR Ltd.. (7/11/23). "Press Release: Ramarketing Announces North American Expansion". 2023-07-11
NK:IO Ltd.. (7/11/23). "Press Release: Imperial Spinout NK:IO Awarded £1.6M Innovate UK New Cancer Therapeutics Grant for Development of Pioneering NK Cell Therapy". London. 2023-07-11
Golgi Neurosciences S.r.l.. (7/5/23). "Press Release: Golgi Neurosciences, a Unique Incubator to Combat Neurodegenerative Disorders, Starts Operating". Milan. 2023-07-05
Camena Bioscience Ltd.. (7/3/23). "Press Release: Camena Bioscience Close $10 Series A Financing as Demand for DNA Synthesis Technology Increases". 2023-07-03
Novacyt S.A.. (7/3/23). "Press Release: Recommended Cash Offer. Novacyt UK Holdings Limited  (a wholly-owned subsidiary of Novacyt S.A.) for Yourgene Health plc [ RESTRICTED]". 2023-07-03
Astraveus S.A.S.. (6/27/23). "Press Release: Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of Its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform". Paris. 2023-06-27
EBD Group. (6/27/23). "Press Release: BIO-Europe 2024 Is Going to Stockholm". Munich. 2023-06-27
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30  next pagenext page


Picture Berlin Partner Voices from HealthCapital Charpentier 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Berlin Partner Special Topic HealthCapital Berlin-Brandenburg 650x300px

» top